“As a long time former CEO of a MedTech specialty supplier, I understand the broad range of technology that most MedTech CDMA’s and CMO’s possess. Company leaders seem to appreciate my knowledge of their technologies and the challenges they face running a MedTech firm. This helps foster mutual respect and trust leading to more opportunities for our clients.”

David Brooks

Director, M&A

David Brooks

David Brooks Form

David Brooks has held several senior executive leadership positions in the orthopaedic, healthcare, scientific instrument, and automotive industries. Based in the U.K., his roles have been oriented towards global markets and has extensive direct experience working and operating across Europe, Asia,  and the Americas.

Most recently, Mr. Brooks was President of Medplast International, prior to its acquisition by Viant Medical. He assumed that position following Medplast’s acquisition of Orthoplastics Ltd, where he was CEO. Mr. Brooks drove Orthoplastics’ global sales initiatives directly, forming strong supplier relationships with all the major orthopaedic OEMs alongside numerous challenger companies on five continents. He also had full P&L responsibility.

Prior to that he held operational leadership positions at Kratos Analytical, now part of Shimadzu in which he led the acquisition process, plus other companies in the automotive sectors. Mr. Brooks has extensive knowledge of operations management techniques including ERP systems and is a six sigma Black Belt.

Mr. Brooks earned his MBA from the Open University in 1995 and has been a certified CIMA accountant since 1980.